Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Fasudil by Woolsey Pharmaceuticals for Progressive Supranuclear Palsy: Likelihood of Approval
Fasudil is under clinical development by Woolsey Pharmaceuticals and currently in Phase II for Progressive Supranuclear Palsy. According to GlobalData,...
Fasudil by Woolsey Pharmaceuticals for Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic Degeneration): Likelihood of Approval
Fasudil is under clinical development by Woolsey Pharmaceuticals and currently in Phase II for Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic Degeneration)....
Fasudil by Woolsey Pharmaceuticals for Amyotrophic Lateral Sclerosis: Likelihood of Approval
Fasudil is under clinical development by Woolsey Pharmaceuticals and currently in Phase II for Amyotrophic Lateral Sclerosis. According to GlobalData,...